Deep brain stimulation in Early Onset Parkinson's disease

Area of Science:

• Neurology
• Neurosurgery

Background:

• Subthalamic Deep Brain Stimulation (STN-DBS) is a recognized treatment for Parkinson's disease (PD) motor symptoms.
• Early-onset Parkinson's disease (EOPD), diagnosed at ≤45-50 years, presents unique challenges due to psychosocial demands.

Purpose of the Study:

• To evaluate the 12-month effects of STN-DBS on motor and non-motor symptoms in EOPD patients.
• To assess changes in medication dosage, quality of life, and neuropsychiatric features post-STN-DBS.

Main Methods:

• Retrospective analysis of 46 EOPD patients undergoing STN-DBS.
• Evaluation of motor, non-motor symptoms, impulsivity, apathy, mood, quality of life, and levodopa equivalent dosage (LEDD) at 12-month follow-up.

Main Results:

• Significant motor score improvement (52.4%) and a 59% reduction in LEDD.
• Significant improvements in impulsivity (6.6 points) and quality of life (30%).
• Reduction in motor/neuropsychiatric features from 41 to 14 patients.

Conclusions:

• STN-DBS offers significant motor and non-motor benefits for EOPD patients, including those with genetic mutations.
• The therapy leads to reduced medication needs and improved quality of life.
• Longitudinal studies are crucial for identifying predictors of STN-DBS outcomes in complex EOPD cases.